Metsera, Inc. Stock Performance

Open N/A	Prev. Close N/A	Circuit Range N/A
Day Range N/A	Year Range N/A	Volume N/A
Average Traded N/A

Metsera, Inc. Share Price Chart

$0.00$0.00

Metsera, Inc. Stock Fundamentals & Key Indicators

Market Cap N/A	PE Ratio (TTM) N/A	Dividend Yield N/A
EPS (TTM) $-14.49	Revenue (TTM) N/A	Return On Equity (TTM) 82.49%
Profit Margin N/A	Debt to Equity -0.27	Quarterly Earnings Growth YoY N/A

Metsera, Inc. Quarterly Profit & Loss

All figures in USD

Particulars	Mar 2025	Jun 2025
Revenue	N/A	N/A
Net Profit	-$76.59M	-$68.72M
Net Profit Margin	N/A	N/A
Income Change	N/A	10.28%

Metsera, Inc. Annual Profit & Loss

All figures in USD

Particulars	2024
Revenue	N/A
Net Profit	-$209.13M
Net Profit Margin	N/A
Income Change	N/A

About Metsera, Inc.

Metsera, Inc., a clinical-stage biotechnology company, develops injectable and oral nutrient stimulated hormone analog peptides to treat obesity, overweight, and related diseases. It develops MET-097i and MET-233i for the treatment of obesity and overweight; MET-233i/MET-097i; and MET-002, MET-224o, MET-067i, and MET-034i to treat disorders, such as diabetes and obesity, as well as MET-815i to reduce weight or prevents weight gain. The company was incorporated in 2022 and is based in New York, New York.

Metsera, Inc. Historical Returns

Month	Open	Close	Change %

MTSR Share Price FAQs

What is Metsera, Inc. share price today?

Metsera, Inc. share price today is $0.00 as on September 18, 2026 at 3:42 pm IST.

What is the 52 week high and 52 week low of Metsera, Inc. stock?

52 week high/low data for Metsera, Inc. is currently unavailable.

What is MTSR's net income for the last quarter?

MTSR's net income for the last quarter is -0.07B USD.

Can I buy MTSR shares in India?

Yes. You can buy MTSR in India by opening an international trading account.